Nyxoah SA Files March 2025 6-K Report
Ticker: NYXH · Form: 6-K · Filed: Mar 13, 2025 · CIK: 1857190
| Field | Detail |
|---|---|
| Company | Nyxoah SA (NYXH) |
| Form Type | 6-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Nyxoah SA filed its March 2025 6-K, standard foreign private issuer update.
AI Summary
Nyxoah SA, a medical device company, filed a Form 6-K on March 13, 2025. The filing is a report of a foreign private issuer for the month of March 2025. Nyxoah SA is incorporated in Belgium and its principal executive offices are located in Mont-Saint-Guibert.
Why It Matters
This filing provides routine updates for investors regarding Nyxoah SA's status as a foreign private issuer, which is important for understanding regulatory compliance and reporting requirements.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain significant new financial or operational information that would typically increase risk.
Key Players & Entities
- Nyxoah SA (company) — Registrant
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (location) — Principal executive office address
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What period does this report cover?
This report is for the month of March 2025.
Where is Nyxoah SA's principal executive office located?
Nyxoah SA's principal executive office is located at Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium.
What is Nyxoah SA's SEC file number?
Nyxoah SA's SEC file number is 001-40552.
Does Nyxoah SA file annual reports under Form 20-F or 40-F?
Nyxoah SA indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 13, 2025 regarding Nyxoah SA (NYXH).